Homo sapiens Protein: OCRL
Summary
InnateDB Protein IDBP-85574.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol OCRL
Protein Name oculocerebrorenal syndrome of Lowe
Synonyms INPP5F; LOCR; NPHL2; OCRL-1; OCRL1;
Species Homo sapiens
Ensembl Protein ENSP00000360154
InnateDB Gene IDBG-85566 (OCRL)
Protein Structure
UniProt Annotation
Function Converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Also converts inositol 1,4,5- trisphosphate to inositol 1,4-bisphosphate and inositol 1,3,4,5- tetrakisphosphate to inositol 1,3,4-trisphosphate. May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes. Involved in primary cilia assembly. {ECO:0000269PubMed:22228094, ECO:0000269PubMed:22543976}.
Subcellular Localization Cytoplasmic vesicle, phagosome membrane {ECO:0000250}. Early endosome membrane. Membrane, clathrin-coated pit. Cell projection, cilium, photoreceptor outer segment. Cytoplasmic vesicle {ECO:0000250}. Endosome {ECO:0000250}. Golgi apparatus, trans-Golgi network {ECO:0000250}. Note=Also found on macropinosomes.
Disease Associations Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]: X- linked multisystem disorder affecting eyes, nervous system, and kidney. It is characterized by hydrophthalmia, cataract, mental retardation, vitamin D-resistant rickets, aminoaciduria, and reduced ammonia production by the kidney. Ocular abnormalities include cataract, glaucoma, microphthalmos, and decreased visual acuity. Developmental delay, hypotonia, behavior abnormalities, and areflexia are also present. Renal tubular involvement is characterized by impaired reabsorption of bicarbonate, amino acids, and phosphate. Musculoskeletal abnormalities such as joint hypermobility, dislocated hips, and fractures may develop as consequences of renal tubular acidosis and hypophosphatemia. Cataract is the only significant manifestation in carriers and is detected by slit-lamp examination. {ECO:0000269PubMed:10767176, ECO:0000269PubMed:10923037, ECO:0000269PubMed:19168822, ECO:0000269PubMed:20133602, ECO:0000269PubMed:21031565, ECO:0000269PubMed:21233288, ECO:0000269PubMed:9199559, ECO:0000269PubMed:9632163, ECO:0000269PubMed:9682219, ECO:0000269PubMed:9788721}. Note=The disease is caused by mutations affecting the gene represented in this entry.Dent disease 2 (DD2) [MIM:300555]: A renal disease belonging to the 'Dent disease complex', a group of disorders characterized by proximal renal tubular defect, hypercalciuria, nephrocalcinosis, and renal insufficiency. The spectrum of phenotypic features is remarkably similar in the various disorders, except for differences in the severity of bone deformities and renal impairment. Characteristic abnormalities include low-molecular-weight proteinuria and other features of Fanconi syndrome, such as glycosuria, aminoaciduria, and phosphaturia, but typically do not include proximal renal tubular acidosis. Progressive renal failure is common, as are nephrocalcinosis and kidney stones. {ECO:0000269PubMed:15627218, ECO:0000269PubMed:17384968, ECO:0000269PubMed:21031565}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Brain, skeletal muscle, heart, kidney, lung, placenta and fibroblasts. Expressed in the retina and the retinal pigment epithelium. {ECO:0000269PubMed:22543976}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 34 experimentally validated interaction(s) in this database.
Experimentally validated
Total 34 [view]
Protein-Protein 33 [view]
Protein-DNA 0
Protein-RNA 1 [view]
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0004439 phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
GO:0005515 protein binding
GO:0030675 Rac GTPase activator activity
GO:0048365 Rac GTPase binding
GO:0052745 inositol phosphate phosphatase activity
Biological Process
GO:0001701 in utero embryonic development
GO:0006629 lipid metabolic process
GO:0006644 phospholipid metabolic process
GO:0006661 phosphatidylinositol biosynthetic process
GO:0007165 signal transduction
GO:0007264 small GTPase mediated signal transduction
GO:0032314 regulation of Rac GTPase activity
GO:0032855 positive regulation of Rac GTPase activity
GO:0042384 cilium assembly
GO:0043647 inositol phosphate metabolic process
GO:0044281 small molecule metabolic process
GO:0046856 phosphatidylinositol dephosphorylation
GO:0051056 regulation of small GTPase mediated signal transduction
Cellular Component
GO:0001750 photoreceptor outer segment
GO:0005622 intracellular
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005769 early endosome
GO:0005795 Golgi stack
GO:0005798 Golgi-associated vesicle
GO:0005802 trans-Golgi network
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005905 coated pit
GO:0030136 clathrin-coated vesicle
GO:0030670 phagocytic vesicle membrane
GO:0031901 early endosome membrane
GO:0070062 extracellular vesicular exosome
Protein Structure and Domains
PDB ID
InterPro IPR000198 Rho GTPase-activating protein domain
IPR000300 Inositol polyphosphate-related phosphatase
IPR005135 Endonuclease/exonuclease/phosphatase
IPR008936 Rho GTPase activation protein
PFAM PF00620
PF03372
PF14529
PRINTS
PIRSF
SMART SM00324
SM00128
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q01968
PhosphoSite PhosphoSite-Q01968
TrEMBL
UniProt Splice Variant
Entrez Gene 4952
UniGene Hs.126357
RefSeq NP_000267
HUGO HGNC:8108
OMIM 300535
CCDS CCDS35393
HPRD 02395
IMGT
EMBL AK293107 AL022162 AL138745 AL662877 BC130612 BC144106 CH471107 M88162 S62085 U57627 Z73496
GenPept AAA59964 AAB03839 AAB26926 AAI30613 AAI44107 BAF85796 CAI41087 CAI41088 CAI42615 CAI42616 CAI95695 CAI95696 EAX11831 EAX11832